Corcept Therapeutics Incorporated CORT
Set alert
80.46 USD -0.66 -0.81%
At close
80.92 +0.46 +0.57%
Pre-market · Nov 3, 7:18 AM ET
79.43 Day range 82.23
28.66 52-week range 126.38
- YTD
- +131.21%
- 1 year
- +8.48%
- Open
- 80.93
- Prev close
- 81.12
- Mkt cap
- 8.70B
- Vol
- 1.59M
- Avg vol
- 1.17M
- EPS
- 0.45
- P/E
- 178.80
- Div yield
- 0.00%
More statistics
- Low
- 79.43
- High
- 82.23
- Forward P/E
- 19.17
- Beta
- 0.56
- Short ratio
- 5.51
- Inst. own
- 76.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 111.98
- 200-d avg
- 74.77
- 1y target
- 141.00
5D chart
Signals (174)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:25 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 3:25 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:20 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 2:40 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 2:25 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 1:55 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:25 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 1:15 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:40 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 11:45 AM | 20 hours ago |
Newest 20 of 174.
Financial health
Altman Z-Score
30.98 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 4
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E 36.6×
FY 2016 5y median 31.8× FY 2025
P/S 4.7×
FY 2016 5y median 6.3× FY 2025
P/B 5.6×
FY 2016 5y median 6.1× FY 2025
P/FCF 25.5×
FY 2016 5y median 25.5× FY 2025
EV/EBITDA 51.2×
FY 2016 5y median 25.4× FY 2025
EV/Sales 4.6×
FY 2016 5y median 6.0× FY 2025
FCF Yield 3.9%
FY 2016 5y median 3.9% FY 2025
Profitability
Gross Margin 98.3%
FY 2016 5y median 98.6% FY 2025
Operating Margin 5.9%
FY 2016 5y median 22.2% FY 2025
Net Margin 13.1%
FY 2016 5y median 22.0% FY 2025
ROE 15.4%
FY 2016 5y median 20.6% FY 2025
ROIC 6.7%
FY 2016 5y median 17.7% FY 2025
ROA 11.9%
FY 2016 5y median 17.1% FY 2025
Growth (YoY)
Revenue 12.8%
FY 2016 FY 2025
Operating Income -67.3%
FY 2016 FY 2025
EPS (diluted) -33.3%
FY 2016 FY 2025
Free Cash Flow -27.6%
FY 2016 FY 2025
Financial Health
Current Ratio 2.9×
FY 2016 5y median 4.4× FY 2025
Quick Ratio 2.8×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.7×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
